Skip to content
Home/Companies/Healthcare/MITEM Pharma
MITEM Pharma

MITEM Pharma

Healthcare·France·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns MITEM Pharma?

MITEM Pharma is currently owned by TechLife Capital through TechLife Capital I (2018 vintage), since 2020.

Hand-verified · updated 2026-04-21

TechLife Capital
Investor
TechLife Capital
TechLife Capital I · 2018 · Growth

Key facts

HQFrance
SectorHealthcare
Websitewww.mitempharma.com

More from TechLife Capital I

Other portfolio companies in the same fund.

RNAlead
RNAlead
Active
HealthcareFrance· 2021
XPath
XPath
Active
HealthcareFrance· 2021
CNSI
Active
TMTFrance· 2020
Maxxing
Maxxing
Exited 2025
TMTFrance· 2020
to
MDT
Active
TMTFrance· 2020
Venn
Active
TMTFrance· 2020

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track MITEM Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy MITEM Pharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on MITEM Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue